AHR is a Zika virus host factor and a candidate target for antiviral therapy
Federico Giovannoni, Irene Bosch, Carolina Manganeli Polonio, María Florencia Torti, Michael A. Wheeler, Zhaorong Li, Leonardo Romorini, María S. Rodriguez Varela, Veit Rothhammer, Andréia Barroso, Emily Tjon, Liliana M. Sanmarco, Maisa C. Takenaka, Seyed Mohamad Sadegh Modaresi, Cristina Gutiérrez‐Vázquez, Nágela Ghabdan Zanluqui, Nilton Barreto dos Santos, Carolina Demarchi Munhoz, Zhongyan Wang, Elsa B. Damonte, David H. Sherr, Lee Gehrke, Jean Pierre Schatzmann Peron, Cybele C. Garcı́a, Francisco J. Quintana
Topics & Concepts
Zika virusFlavivirusVirologyMicrocephalyViral replicationBiologyDengue virusImmunityImmunologyAryl hydrocarbon receptorVirusTranscription factorImmune systemGeneticsGeneMosquito-borne diseases and controlHIV Research and TreatmentViral Infections and Vectors